Taysha Gene Therapies, Inc. Common Stock

Taysha Gene Therapies Soars on Breakthrough Designation

Taysha Gene Therapies shares are trading higher after the company announced it received FDA Breakthrough Therapy designation for its gene therapy product TSHA-102 in Rett Syndrome.